Helen Tremlett

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. pmc Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance
    Ruth Ann Marrie
    Department of Internal Medicine, University of Manitoba, Winnipeg, Canada
    BMC Neurol 13:16. 2013
  2. ncbi request reprint Natural, innate improvements in multiple sclerosis disability
    Helen Tremlett
    Faculty of Medicine, Division of Neurology, University of British Columbia, Vancouver, BC, Canada
    Mult Scler 18:1412-21. 2012
  3. doi request reprint Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts
    Elaine Kingwell
    Faculty of Medicine Neurology, Multiple Sclerosis Program, UBC Hospital, 2211 Wesbrook Mall, University of British Columbia, Vancouver, BC, Canada V6T 2B5
    J Neurol Sci 292:57-62. 2010
  4. doi request reprint Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis
    Afsaneh Shirani
    Division of Neurology and Brain Research Centre, Department of Medicine and Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, Canada
    JAMA 308:247-56. 2012
  5. pmc Birth hospitalization in mothers with multiple sclerosis and their newborns
    Ellen Lu
    Department of Medicine, Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada
    Neurology 80:447-52. 2013
  6. doi request reprint Monthly ambient sunlight, infections and relapse rates in multiple sclerosis
    Helen Tremlett
    Faculty of Medicine Neurology, University of British Columbia, Vancouver, B C, Canada
    Neuroepidemiology 31:271-9. 2008
  7. doi request reprint Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance
    Ellen Lu
    Department of Medicine, Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
    Expert Rev Neurother 13:251-60; quiz 261. 2013
  8. doi request reprint Natural history of secondary-progressive multiple sclerosis
    Helen Tremlett
    Department of Medicine Neurology, rm S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver BC V6T 2B5, Canada
    Mult Scler 14:314-24. 2008
  9. doi request reprint Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities
    Helen Tremlett
    Dept of Medicine Neurology, rm S178, 2211 Wesbrook Mal, University of British Columbia, Vancouver, BC V6T 2B5, Canada
    J Neurol 256:374-81. 2009
  10. doi request reprint Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009)
    Afsaneh Shirani
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Mult Scler 18:442-50. 2012

Collaborators

  • Joel Oger
  • Feng Zhu
  • B Jones
  • D Adams
  • Anne Louise Ponsonby
  • A Dessa Sadovnick
  • Fiona Costello
  • Peter Rieckmann
  • Mark S Pearce
  • Bruce Taylor
  • Michael Hutchinson
  • D Craig
  • Norm Phillips
  • Marcus Koch
  • Elaine Kingwell
  • Ana Luiza Sayao
  • Ellen Lu
  • Charity Evans
  • Afsaneh Shirani
  • Yinshan Zhao
  • Anne Synnes
  • Mia L van der Kop
  • Jameelah Saeedi
  • Leanne Dahlgren
  • Ruth Ann Marrie
  • Alex P Lange
  • Pedro Lourenco
  • Bing Wei Wang
  • Colleen Guimond
  • Dessa Sadovnick
  • Virginia Devonshire
  • Lawrence Elliott
  • Bo Nancy Yu
  • William E Schreiber
  • Samir Alkabie
  • John D Fisk
  • Lawrence W Svenson
  • Anthony Traboulsee
  • James F Blanchard
  • Sharon Warren
  • Stella Leung
  • Anthony L Traboulsee
  • Reza Sadjadi
  • Christina Wolfson
  • Patricia Caetano
  • Scott B Patten
  • Irene Yee
  • John Petkau
  • Jennifer Tam
  • Stanley Hashimoto
  • Paul Gustafson
  • Chris Bajdik
  • Mohammad Ehsanul Karim
  • Anna Marie Bueno
  • D Parton
  • Pierre Duquette
  • Alexander L Leung
  • L Kastrukoff
  • T Traboulsee
  • S Meckling
  • O Hiebiceck
  • V Devonshire
  • D Paty
  • W Shtybel
  • S Hashimoto
  • P Smyth
  • L Daly
  • Elaine Roger
  • J Hooge

Detail Information

Publications27

  1. pmc Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance
    Ruth Ann Marrie
    Department of Internal Medicine, University of Manitoba, Winnipeg, Canada
    BMC Neurol 13:16. 2013
    ..We validated and applied administrative case definitions for any mental comorbidities in MS...
  2. ncbi request reprint Natural, innate improvements in multiple sclerosis disability
    Helen Tremlett
    Faculty of Medicine, Division of Neurology, University of British Columbia, Vancouver, BC, Canada
    Mult Scler 18:1412-21. 2012
    ..However, improvements have rarely been examined in natural history or IMD naive patients. We investigated annual and biennial improvements in Expanded Disability Status Scale (EDSS) scores in British Columbia, Canada...
  3. doi request reprint Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts
    Elaine Kingwell
    Faculty of Medicine Neurology, Multiple Sclerosis Program, UBC Hospital, 2211 Wesbrook Mall, University of British Columbia, Vancouver, BC, Canada V6T 2B5
    J Neurol Sci 292:57-62. 2010
    ..001). If early intervention at mild disability levels is warranted in MS, then the extended delays to medical recognition for young adult-onset and PPMS patients must be addressed...
  4. doi request reprint Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis
    Afsaneh Shirani
    Division of Neurology and Brain Research Centre, Department of Medicine and Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, Canada
    JAMA 308:247-56. 2012
    ..Interferon beta is widely prescribed to treat multiple sclerosis (MS); however, its relationship with disability progression has yet to be established...
  5. pmc Birth hospitalization in mothers with multiple sclerosis and their newborns
    Ellen Lu
    Department of Medicine, Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada
    Neurology 80:447-52. 2013
    ....
  6. doi request reprint Monthly ambient sunlight, infections and relapse rates in multiple sclerosis
    Helen Tremlett
    Faculty of Medicine Neurology, University of British Columbia, Vancouver, B C, Canada
    Neuroepidemiology 31:271-9. 2008
    ..Monthly variation in multiple sclerosis (MS) relapses has been found. The relationship between seasonal environmental factors, infections, serum vitamin D [25(OH)D] and MS relapses is undetermined...
  7. doi request reprint Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance
    Ellen Lu
    Department of Medicine, Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
    Expert Rev Neurother 13:251-60; quiz 261. 2013
    ..Future pharmacovigilance studies should continue to pursue multicenter collaboration with an emphasis on appropriate study design...
  8. doi request reprint Natural history of secondary-progressive multiple sclerosis
    Helen Tremlett
    Department of Medicine Neurology, rm S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver BC V6T 2B5, Canada
    Mult Scler 14:314-24. 2008
    ..To examine prognosis and risk factors for progression to and from secondary-progressive multiple sclerosis (SPMS)...
  9. doi request reprint Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities
    Helen Tremlett
    Dept of Medicine Neurology, rm S178, 2211 Wesbrook Mal, University of British Columbia, Vancouver, BC V6T 2B5, Canada
    J Neurol 256:374-81. 2009
    ..We aimed to examine how this phenomenon impacts on demographic and clinical comparisons made between PP and SPMS...
  10. doi request reprint Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009)
    Afsaneh Shirani
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Mult Scler 18:442-50. 2012
    ..Recent natural history studies suggest that multiple sclerosis (MS) is a more slowly progressing disease than previously thought. These observations are from studies separated by time, geography and methodological approach...
  11. ncbi request reprint Longitudinal follow-up of "benign" multiple sclerosis at 20 years
    Ana Luiza Sayao
    Department of Medicine Neurology, University of British Columbia, Vancouver, BC, Canada
    Neurology 68:496-500. 2007
    ..To evaluate disease status after 20 years in a cohort defined as "benign multiple sclerosis (MS)" (Expanded Disability Status Scale [EDSS] score < or = 3) at 10 years from onset...
  12. ncbi request reprint Disability progression in multiple sclerosis is slower than previously reported
    Helen Tremlett
    Department of Medicine Neurology, University of British Columbia, Vancouver, Canada
    Neurology 66:172-7. 2006
    ..To investigate disease progression and risk factors in a large geographically based population with multiple sclerosis (MS), using two different inception points--clinical onset and date of birth...
  13. ncbi request reprint Is late-onset multiple sclerosis associated with a worse outcome?
    Helen Tremlett
    Department of Medicine Neurology, rm S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver, BC V6T 2B5, Canada
    Neurology 67:954-9. 2006
    ..To describe the characteristics of late-onset multiple sclerosis (MS) (LOMS, 50+ years) vs adult-onset MS (AOMS, 16 to <50 years) and examine prognosis and associated risk factors...
  14. doi request reprint Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada
    Jameelah Saeedi
    Faculty of Medicine, Division of Neurology, Multiple Sclerosis Program, University of British Columbia, Vancouver, BC, Canada
    Mult Scler 18:1239-43. 2012
    ..The objectives of this study were to identify and describe the demographic and clinical characteristics of multiple sclerosis (MS) in aboriginals in British Columbia (BC), Canada and compare these findings with non-aboriginal MS patients...
  15. doi request reprint Cancer risk in multiple sclerosis: findings from British Columbia, Canada
    Elaine Kingwell
    Division of Neurology, Faculty of Medicine, Multiple Sclerosis Program, University of British Columbia, Vancouver, British Columbia, Canada
    Brain 135:2973-9. 2012
    ..The larger tumour sizes at cancer diagnosis suggested diagnostic neglect; this could have major implications for the health, well-being and longevity of people with multiple sclerosis...
  16. doi request reprint Long-term persistence with the immunomodulatory drugs for multiple sclerosis: a retrospective database study
    Charity Evans
    Faculty of Medicine Neurology, University of British Columbia, Vancouver, British Columbia, Canada
    Clin Ther 34:341-50. 2012
    ..However, relatively little is known about the long-term persistence to these drugs...
  17. doi request reprint The natural history of primary progressive multiple sclerosis
    Marcus Koch
    Faculty of Medicine, Division of Neurology, University of British Columbia, Vancouver, Canada
    Neurology 73:1996-2002. 2009
    ..Here, we extend previous analyses in an updated PPMS retrospective cohort study of prevalent cases...
  18. ncbi request reprint Hospital admissions and MS: temporal trends and patient characteristics
    Charity Evans
    Faculty of Medicine Neurology, University of British Columbia, Vancouver, Canada
    Am J Manag Care 18:735-42. 2012
    ..We examined hospital admission rates and patterns in a large Canadian MS cohort...
  19. pmc Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review
    Ellen Lu
    Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada
    Neurology 79:1130-5. 2012
    ..To systematically review the literature regarding safety of disease-modifying drug (DMD) use during pregnancy on perinatal and developmental outcomes in offspring of patients with multiple sclerosis (MS)...
  20. doi request reprint The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis
    Ana Luiza Sayao
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Mult Scler 17:1375-83. 2011
    ..We set out to examine important psychosocial and cognitive outcomes in patients with longstanding BMS compared with patients who had recently progressed to 'no longer benign' (NLB)...
  21. doi request reprint New perspectives in the natural history of multiple sclerosis
    Helen Tremlett
    Faculty of Medicine, Division of Neurology, Multiple Sclerosis Program, University of British Columbia, Vancouver, Canada
    Neurology 74:2004-15. 2010
    ....
  22. doi request reprint Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression
    Pedro Lourenco
    Faculty of Medicine, University of British Columbia, Vancouver, Canada
    Mult Scler 19:577-84. 2013
    ..The use of oligoclonal bands (OCBs) and cerebrospinal fluid (CSF) parameters are established in the diagnosis of MS, but poorly as markers of disease...
  23. pmc Neonatal and delivery outcomes in women with multiple sclerosis
    Mia L van der Kop
    Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada
    Ann Neurol 70:41-50. 2011
    ..To determine (1) whether the risk of adverse neonatal and delivery outcomes differs between mothers with and without multiple sclerosis (MS) and (2) whether risk is differentially associated with clinical factors of MS...
  24. doi request reprint Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses
    Helen Tremlett
    Faculty of Medicine Neurology, University of British Columbia, Canada
    Pharmacoepidemiol Drug Saf 17:565-76. 2008
    ..We examined both levels of non-adherence-stopping IMD and missing doses...
  25. ncbi request reprint The natural history of primary progressive MS in British Columbia, Canada
    Helen Tremlett
    Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada
    Neurology 65:1919-23. 2005
    ..The authors examined patient characteristics, disease progression, and associated risk factors in the PP population of British Columbia, Canada...
  26. doi request reprint Retinal nerve fiber layer thickness in benign multiple sclerosis
    Alex P Lange
    Neuro Ophthalmology, Department of Ophthalmology, University of British Columbia, Canada
    Mult Scler 19:1275-81. 2013
    ..Retinal nerve fiber layer (RNFL) thickness has been linked to brain atrophy in multiple sclerosis (MS). However, little is known about retinal atrophy in 'benign' MS. We compared RNFL thickness in benign MS with healthy controls...
  27. ncbi request reprint Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis
    Helen Tremlett
    Department of Medicine Neurology rm S159, Vancouver Hospital and Health Sciences Centre, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada
    J Neurol 251:1297-303. 2004
    ..However, testing will probably not prevent the Type B idiosyncratic reactions which can result in severe hepatic injury; hence patients need to be aware, and to report hepatic side effects promptly...